Search


Guide to Wholesaling & Brokering of Medicinal Products - Ireland
The Health Products Regulatory Authority (HPRA) Ireland released updated guidance on the "Guide to Wholesaling and Brokering of...

Sharan Murugan
Mar 30, 20221 min read
Â
Â


Guidance on Requirements for Import / Re-export Medical Imaging Materials - SFDA
On 27 March,2022 the Saudi Food and Drug Authority (SFDA) released this guidance detailing the Requirements for the Import and Clearance...

Sharan Murugan
Mar 30, 20221 min read
Â
Â


Guide on Microplastic Usage - IPEC Europe and IPEC-Americas "How to Document"
A new how-to guide was published by the International Pharmaceutical Excipients Council (IPEC) to assist the pharmaceutical industry in...

Sharan Murugan
Mar 30, 20221 min read
Â
Â


EMA Guidance on Post-Authorisation Procedural Advice for CAP users & EudraVigilance Reg. Manual
On 18 March 2022, EMA released updated guidance on "European Medicines Agency post-authorisation procedural advice for users of the...

Sharan Murugan
Mar 24, 20221 min read
Â
Â


USFDA's recent Guidance on Biologics: Ophthalmic Products & Development of (CAR) T Cell Products
1. Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR This guidance is intended to provide information to applicants...

Sharan Murugan
Mar 24, 20221 min read
Â
Â


EMA Guidance on GVP for PPP & Parallel EMA/EUnetHTA 21 Consultation
Guideline on Good Pharmacovigilance Practices (GVP) for Pregnancy Prevention Programs A public consultation was launched by the European...

Sharan Murugan
Mar 24, 20222 min read
Â
Â


Guidance on Renewal & Discontinuation of Authorisation on change of Status -Swiss Medic
This guidance document describes the rules that apply to the renewal or discontinuation of authorisation, how these rules are to be...

Sharan Murugan
Mar 24, 20221 min read
Â
Â


Malaysia Draft Medical Device Guidance on PERSONAL PROTECTIVE EQUIPMENT (PPE) - REQUIREMENTS
The Malaysian Medical Device Authority (MDA) drafted a guideline on personal protective equipment (PPE) and seeks feedback from the...

Sharan Murugan
Mar 24, 20221 min read
Â
Â


UK MHRA: Guidance on "Advertise your Medicines"
The MHRA on 17-March-2022 updated its Guidance on Advertise your medicines which details how to comply with the requirements on promoting...

Sharan Murugan
Mar 24, 20221 min read
Â
Â


FDA's: OTC Monograph Drug User Fees for Fiscal Year 2022
Yesterday USFDA published the fees for over-the-counter (OTC) monograph drugs for fiscal year (FY) 2022 in a Federal Register Notice...

Sharan Murugan
Mar 15, 20221 min read
Â
Â


SwissMedic Guidance on Packaging for Human Medicinal Products
On 11-March-2022, SwissMedic released updated guidance on "Packaging for Human Medicinal Products". The purpose of this document is to...

Sharan Murugan
Mar 13, 20221 min read
Â
Â


USFDA Guidance on Verification Systems & Voluntary Recalls
FDA is issuing this draft guidance "Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs Guidance...

Sharan Murugan
Mar 13, 20221 min read
Â
Â


UK (MHRA) Project Orbis Guidance Update & New Guidance on Dialysis
Project Orbis aims to review and approve promising cancer treatments to help patients access treatment faster. MHRA recently added...

Sharan Murugan
Mar 13, 20221 min read
Â
Â


USFDA: 3 updated Guidance on PLAIR, VQIP & Recalls
As a result of this guidance, the July 2013 draft guidance Pre-Launch Activities Importation Requests (PLAIR) has been finalized, which...

Sharan Murugan
Mar 6, 20222 min read
Â
Â


South Africa (SAHPRA) Guidance on How to Submit Variation Applications
The purpose of this document is to inform applicants on how to submit variations to the South African Health Products Regulatory...

Sharan Murugan
Mar 6, 20221 min read
Â
Â


MHRA adds Health Technology Assessments (HTA) Tool Details to ILAP Guide
MHRA, the UK Medicines and Healthcare Products Regulatory Agency has updated its guidance information on the Innovative Licensing and...

Sharan Murugan
Mar 6, 20221 min read
Â
Â